Genomic Prediction provides advanced genomic tests which improve IVF health outcomes. PGT-P is the
10/14/2024
We cannot wait to see you at booth #160 at in Denver!
Come chat with us about the abstracts and posters we will be presenting while at the conference, learn more about our Embryo Health Score Test, speak to our team about best practices, and more!
02/23/2024
We stand with those fighting to build their families.
02/11/2024
International Day of Women & Girls in Science:
The International Day of Women and Girls in Science is an annual observance adopted by the United Nations General Assembly to promote the full and equal access and participation of women in Science, Technology, Engineering and Mathematics fields.
Look around our headquarters and you will see many of the amazing women we are so humbled to work with daily!
01/02/2024
Top 9 Instagram posts of 2023! Drop a comment below ⬇️ to let us know what you want to see more of in 2024!
12/30/2023
12/28/2023
42 years ago today, Elizabeth Carr, the 1st USA IVF baby, was born! Since then, millions of babies have been born worldwide via IVF.
Elizabeth uses her life to advocate for infertility rights and family-building coverage; she’s the Head of Marketing, Public Relations, and Patient Advocacy at LifeView.
Happy 42 to Elizabeth! We are thankful for your life!
Original photo by David McGlynn
12/27/2023
As the year comes to a close and a new year is about to begin we asked some of our leadership team what they’re looking forward to in 2024. This is what our CCO, Marsha had to say!
12/15/2023
As we move into the last days of 2023, we are reminded of all the patients we have had the opportunity to help throughout the year. We are so grateful that you trust us to serve your patients and their genetic testing needs. In order to continue to meet the needs of your patients, we will remain open during the holiday season. Due to transportation limitations, please note the following dates when samples can be received and administrative offices will be open.
12/01/2023
And there you have it folks, it’s a wrap!
11/23/2023
With so much love and gratitude, Happy Thanksgiving!
11/20/2023
Mark your calendars, next week Wednesday, Nov 29th, Kellee Stewart will host an Insta LIVE to interview with 1st USA IVF baby & Genomic Prediction’s Head of Marketing, Public Relations, and Patient Advocacy, Elizabeth Carr!
Repost from
•
💃🏽WARRIOR WEDNESDAYS‼️The FIRST IVF BABY BORN in the United States is kicking off Season 2 of WARRIOR WEDNESDAYS!! 💃🏽 My dear friend Elizabeth Carr brings her historical birth to the Warrior family LIVE on Wednesday November 29th at 10:00AM EST‼️ Don’t miss this incredible conversation with the woman that marked fertility history 41 years ago!! She’s a journalist, author, advocate, works in fertility at a Preimplantation Genetic Testing lab…but most importantly a wife, mother, and INCREDIBLE HUMAN❤️!! Hear all about her birth story and her mission to continue to fight for our rights to safely build families. Join us bright and early on November 29th!! ☀️ Warriors…we’re BACK‼️
11/16/2023
A recent collaborative study had some pretty big findings that we think everyone should know about. Elizabeth Carr, USA-1st IVF baby had this to say,
“Today IVF remains an overwhelming process for most patients and they need to be informed that there are significant differences in testing platforms including the number of embryos a patient will have to transfer.” - Elizabeth Carr (1st USA-IVF Baby)
To learn more click the link in our stories or set up a call with our IVF nurse on staff: Talia@genomicprediction.com
Be the first to know and let us send you an email when Genomic Prediction posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Genomic Prediction provides advanced genomic tests which improve IVF health outcomes.
Genomic Prediction Inc. (GP) was incorporated in Delaware, May 1, 2017.
The research insights which led to the creation of GP stretch back much further. Research and data exchange agreements to develop molecular methodology, signed with some of the largest biotechnology vendors in the world, were ongoing as early as 2015. In the decade prior, the founders’ work in embryology, detection of chromosomal abnormality, computational genomics, algorithms, and polygenic architecture led to GP’s superior and innovative methodology for the genetic testing of human embryos. GP’s products incorporate fundamental improvements on existing methods.
GP offers IVF parents a cost-effective means to evaluate genetic risk due to chromosomal abnormality (ploidy), single-gene mutations, and polygenic diseases.
Accurate understanding of the genomic architecture of human disease requires larger training datasets, greater accuracy, and a more rigorous, empirical basis of computational modeling (machine learning) than implemented in the past with simpler technologies and simpler computational methods. GP represents the next step in embryo genetic testing, combining dense, genome-wide genotyping methods with sophisticated validation-focused modeling, suitable for the information age.